This trial is studying how well hyperpolarized xenon MRI works in children who have had a lung transplant for chronic lung allograft dysfunction.
1 Primary · 2 Secondary · Reporting Duration: baseline to 6-month follow-up
Experimental Treatment
20 Total Participants · 1 Treatment Group
Primary Treatment: Hyperpolarized 129-Xenon (MagniXene) MRI of the lung · No Placebo Group · Phase 1
Age 8 - 20 · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: